Pantoprazole 40mg (Special Aristo Dye)
Pantoprazole 40mg — irreversible H⁺/K⁺-ATPase proton pump inhibitor. Pantoprazole has the lowest CYP2C19 drug interaction liability among PPIs and the most extensive IV-to-oral evidence base, making it the preferred PPI in complex polypharmacy patients and post-surgical step-down. Special Aristo Dye provides visual batch identification. Alu packaging (10×15 = 150 tablets per box) provides an economy format for chronic prescribing.
Peptic ulcer disease, GORD, H. pylori eradication (PPI component), NSAID-associated ulcer prophylaxis, Zollinger-Ellison syndrome, laryngopharyngeal reflux, and stress ulcer prophylaxis. The 150-tablet pack covers 5 months of once-daily therapy — suited for chronic maintenance prescribing.
Dosage and administration should be as prescribed by a qualified doctor or medical professional. Do not self-medicate. Always follow your physician's instructions regarding dose, frequency and duration of treatment.
PANSWING™ 40's economy 150-tablet format serves the high-volume chronic GORD prescribing market where monthly repeat prescriptions create compliance friction. A single box covering 5 months eliminates 4 pharmacy visits for stable GORD patients on maintenance therapy.
Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.